BioSpace News Archive

Progress Flickers in Women’s Healthcare as Femtech Builds Traction

The worldwide market for therapeutics designed specifically for conditions and diseases that affect mainly women is expected to exceed $65 billion by 2027. BioSpace looks at three femtech leaders.

December 5, 2022
·
7 min read
·
Gail Dutton
Drug Development

In Face of Multiple Patent Cliffs, Novartis’ Prostate Cancer Drug Shows Promise

Novartis announced the Phase III PSMAfore trial of Pluvicto for PSMA-positive metastatic castration-resistant prostate cancer met its primary endpoint.

December 5, 2022
·
3 min read
·
Mark Terry
Business

SonoThera Bags $60M for Ultrasound-Guided, Non-Viral Gene Therapy

SonoThera closed its Series A round of financing Monday, counting $60.75 million in earnings and will use these proceeds to advance its ultrasound-guided, non-viral gene therapy platform.

December 5, 2022
·
2 min read
·
Tristan Manalac
Business

Top Life Sciences Startups to Watch in 2023

BioSpace is proud to present its NextGen Bio “Class of 2023,” a list of the hottest recently launched life sciences companies in North America.

December 5, 2022
·
15 min read
·
BioSpace Editorial Staff
Job Trends

Protracted Job Searches Exact Weighty Mental Health Toll

Whether a job search is voluntary or not, months of interviews, wrangling over pay and benefits and evaluating options has a weighty psychological toll.

December 5, 2022
·
4 min read
·
Lisa Munger
Deals

Janssen Bows Out as Contender for Horizon Therapeutics Buyout

Janssen (Johnson & Johnson) is no longer in the running to acquire rare disease player Horizon Therapeutics, the company announced Saturday. This leaves Amgen and Sanofi at the bidding table.

December 5, 2022
·
2 min read
·
Heather McKenzie
Drug Development

FDA Outlines Path Forward for Verve’s Lead Candidate, VERVE-101

Monday, Verve Therapeutics revealed that the FDA has officially requested several buckets of additional safety information to lift the hold on its lead candidate, VERVE-101.

December 5, 2022
·
2 min read
·
Editorial Staff
DNA Sequencing Market Size & Share to Surpass $ 12.6 Billion by 2028 | Vantage Market Research

The Global DNA Sequencing Market was valued at USD 4.8 Billion in 2021, and the global DNA sequencing industry is anticipated to reach a value of USD 12.6 Billion by 2028 at a CAGR (Compound Annual Growth Rate) of 17.5% over the forecast period.

December 5, 2022
·
4 min read
BioCapital

Delaware Imaging Network Launches the Enhanced Breast Cancer Detection Program, Providing Women a New State-of-the-Art Solution Powered by Artificial Intelligence

Delaware Imaging Network, a division of RadNet, Inc., announced that it has started implementation of its new Enhanced Breast Cancer Detection service, which works in concert with a patient’s annual breast screening regimen.

December 5, 2022
·
4 min read
Business

Roche Announces Brad Moore as President and CEO of Roche Diagnostics North America

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the appointment of Brad Moore as president and CEO of Roche Diagnostics North America, effective January 1, 2023.

December 5, 2022
·
2 min read